tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market

Chugai Pharmaceutical Co (CHGCF) Financial Statements

Compare
22 Followers

Chugai Pharmaceutical Co Financial Overview

Chugai Pharmaceutical Co's market cap is currently $106.06B. The company's EPS TTM is $0.49611474; its P/E ratio is 38.61; and it has a dividend yield of 2.38%. Chugai Pharmaceutical Co is scheduled to report earnings on January 29, 2026, and the estimated EPS forecast is $0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.26T¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B
Gross Profit¥ 894.25B¥ 830.75B¥ 693.01B¥ 783.06B¥ 660.27B
Operating Income¥ 590.19B¥ 543.91B¥ 415.67B¥ 533.94B¥ 433.74B
EBITDA¥ 631.37B¥ 574.80B¥ 475.64B¥ 562.66B¥ 450.30B
Net Income¥ 434.01B¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B
Balance Sheet
Cash & Short-Term Investments¥ 979.70B¥ 996.35B¥ 738.98B¥ 503.11B¥ 471.97B
Total Assets¥ 2.47T¥ 2.21T¥ 1.93T¥ 1.87T¥ 1.54T
Total Debt¥ 0.00¥ 10.90B¥ 13.46B¥ 14.11B¥ 16.04B
Net Debt¥ -426.60B¥ -529.30B¥ -445.22B¥ -208.06B¥ -251.71B
Total Liabilities¥ 442.86B¥ 306.87B¥ 306.97B¥ 445.37B¥ 350.68B
Stockholders' Equity¥ 2.03T¥ 1.90T¥ 1.63T¥ 1.42T¥ 1.19T
Cash Flow
Free Cash Flow¥ 313.18B¥ 396.68B¥ 335.67B¥ 172.87B¥ 206.76B
Operating Cash Flow¥ 389.45B¥ 447.60B¥ 409.93B¥ 244.11B¥ 279.63B
Investing Cash Flow¥ -204.87B¥ -227.37B¥ -37.29B¥ -145.99B¥ -118.93B
Financing Cash Flow¥ -307.46B¥ -141.01B¥ -139.33B¥ -145.64B¥ -107.41B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History

Chugai Pharmaceutical Co Debt to Assets

Chugai Pharmaceutical Co Cash Flow

Chugai Pharmaceutical Co Forecast EPS vs Actual EPS